Bausch Health Companies Inc. (BHC) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Greetings, and welcome to the Boush Health fourth quarter and full year 2025 earnings conference call and webcast. At this time, all participants are in listen-only mode. A question and answer session will follow the formal presentation. You will be placed into question queue at any time by pressing star 1 on your telephone keypad. We ask that you ask one question, one follow-up, and return to the queue. As a reminder, this conference is being recorded. If anyone should require operator assistance, please press star zero. It's now my pleasure to turn the call over to your host, Garen Serafian, Vice President, Investor Relations. Garen, please go ahead. Good afternoon, and welcome to Bosch Health's fourth quarter and full year 2025 earnings conference call. My name is Garen Serafian, Vice President of Investor Relations. Participating in today's call are Thomas Appio, Chief Executive Officer, JJ Chiron, Chief Financial Officer, and Jonathan Sade, Chief Medical Officer and Head of Research and Development. Before we begin, I would like to remind you that today's presentation contains forward-looking information. Please take a moment to review the forward-looking statements disclaimer at the beginning of the slides accompanying this presentation, as it contains important information. Actual results may differ materially from those expressed or implied in these forward-looking statements, and you should not place undue reliance on them. Please also refer to our SEC filings and our filings with the Canadian Securities Administrators for discussion of certain risk factors that could cause actual results to differ materially from expectations. We use non-GAAP financial measures to help investors better understand our operating performance. These non-GAAP measures may not be...